newsweek.ro/sanatate/sanatate-cancer-la-prostata-e
Researchers at the University of British Columbia have identified a hereditary form of prostate cancer linked to a rare genetic mutation, CDK12, which can lead to aggressive disease in younger individuals. This discovery may enable earlier identification of families at risk and facilitate preventive screening. The study analyzed genetic data from over 4,500 patients, revealing that five men with these mutations developed metastatic prostate cancer between ages 44 and 62. The findings suggest that hereditary mutations, although rare, could significantly impact cancer screening and treatment options for affected families.
Fact-check this story: paste the text or link into Justificat.ro and get a verdict with the sources consulted.